等待開盤 10-22 09:30:00 美东时间
-0.050
-1.38%
AUSTIN, Texas, Aug. 19, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Ailer...
08-20 04:05
Aileron Therapeutics, Inc. Q2 Operating Expenses USD 9.039 Million
08-15 06:05
Aileron Therapeutics, Inc. Q2 Basic EPS USD -0.45
08-15 06:05
Aileron Therapeutics, Inc. Q2 Net Income USD -8.942 Million
08-15 06:05
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business...
08-15 06:05
Aileron Therapeutics Inc - Qtrly Shr Loss $0.45
08-15 05:59
Aileron Therapeutics: Got Into Equity Distribution Agreement, May Offer & S...
07-27 04:37
Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and
07-01 20:12
Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.14) by 514.29 percent.
05-16 05:13
Gainers: Bio-Path Holdings (BPTH) +69%. Aileron Therapeutics (ALRN) +51%. SINTX Technologies (SINT) +42%. Expion360 (XPON) +30%. Swvl Holdings Corp (SWVL) +27%. MicroCloud Hologram (HOLO) +27%. Mawson...
04-19 00:42